UK Companies House feature
MENTHOLATUM COMPANY LIMITED(THE)
Profile
- Company number
- 00197071
- Status
- Active
- Incorporation
- 1924-04-07
- Last accounts made up
- 2025-02-28
- Account category
- FULL
- Primary SIC
- 21100
- Hubs
- UK Healthcare
Accounts
Pending extraction
Audit & accounting basis
From AI-extracted PDF accounts
- Accounting basis
- FRS 102
- Reporting scope
- Standalone (parent only)
- Auditor
- Ernst & Young LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“The directors, having made their own assessment of the company's financial position have a reasonable expectation that the company has adequate financial resources to continue to operate for the foreseeable future. Accordingly, they continue to adopt the going concern basis in preparing the annual report and accounts.”
Subsidiaries
- Mentholatum (Overseas) Limited · 100% held · England · Holding company
- Mentholatum South Africa (Pty) Limited · 100% held · South Africa · OTC Pharmaceuticals
- A.J. North (Pty) Limited · 100% held · South Africa · Manufacturing
- The Mentholatum Company (Ireland) Limited · 100% held · Ireland · Manufacturing
Significant events
- “In early March 2025, the company's primary supplier of aluminium tubes informed us that they would be closing their business due to financial challenges and macroeconomic policy shifts. This event created uncertainty regarding the continuity of supply for a key packaging item, essential for our gels and creams production processes, and impacting roughly 50% of our product portfolio.”
- “Post year end, but prior to the approval of the financial statements, the board has approved an interim dividend of £1,413,980 (2024: £1,747,430). This dividend has not yet been paid.”
Auditor / going-concern / subsidiary information is extracted from the PDF version of the latest annual accounts and is not tagged in iXBRL. About these numbers
People
7 active · 16 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| MCCOLGAN, Linda Anne | Secretary | 2018-09-01 | — | — |
| HOSSENLOPP, Steve | Director | 2012-11-30 | Jan 1965 | American |
| IZON, Michael Trevor | Director | 2021-08-18 | Jun 1968 | British |
| LAWLOR, Andrew John | Director | 2024-09-01 | Jan 1981 | South African |
| MCCOLGAN, Linda Anne | Director | 2018-09-01 | Jun 1972 | Scottish |
| MISZTAK, Maciej Adam | Director | 2016-08-22 | Apr 1972 | Polish |
| SAITO, Masaya | Director | 2018-10-15 | Nov 1963 | Japanese |
Show 16 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| HOSSENLOPP, Steve | Secretary | 2017-10-31 | 2018-09-01 |
| OGLESBY, Howard | Secretary | — | 1995-03-31 |
| SMART, Douglas John | Secretary | 1995-03-31 | 2017-10-31 |
| BROWN, Colin Martin | Director | 2017-10-31 | 2020-12-14 |
| CHAN, Francis Wai Pok | Director | — | 2012-11-30 |
| CRANDALL, Robert Mason | Director | — | 1993-06-16 |
| GORNY, Bronislaw Waclaw Mackie | Director | 2012-02-06 | 2015-09-01 |
| GORNY, Bronislaw Waclaw Mackie | Director | 1991-11-04 | 2007-07-31 |
| HENDERSON, Kenneth Murray | Director | — | 1992-02-28 |
| INGHAM, James Warren | Director | — | 2010-08-06 |
| OGLESBY, Howard | Director | — | 1995-03-31 |
| SMART, Douglas John | Director | 1994-11-29 | 2017-10-31 |
| TASKER, Andrew Paul | Director | 2007-07-31 | 2012-01-31 |
| YATEMAN, Robert William | Director | 2015-03-02 | 2024-08-31 |
| YOSHIDA, Akiyoshi | Director | 1999-11-04 | 2018-06-25 |
| YOSHIDA, Masashi | Director | 1993-06-16 | 1999-11-04 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| The Mentholatum Company Inc | Corporate entity | Shares 75–100%, Voting 75–100% | 2021-08-18 | Active |
| Mr Robert William Yateman | Individual | Significant influence | 2016-05-31 | Ceased 2021-08-18 |
| Mr Douglas John Smart | Individual | Significant influence | 2016-05-31 | Ceased 2017-10-31 |
Filing timeline
Last 20 of 161 total filings
| Date | Type | Category | Description |
|---|---|---|---|
| 2026-03-23 | CH01 | officers | change person director company with change date |
| 2025-10-24 | AA | accounts | accounts with accounts type full |
| 2025-08-18 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2025-06-25 | MR04 | mortgage | mortgage satisfy charge full |
| 2025-05-19 | MR04 | mortgage | mortgage satisfy charge full |
| 2024-09-02 | AP01 | officers | appoint person director company with name date |
| 2024-09-02 | TM01 | officers | termination director company with name termination date |
| 2024-08-16 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2024-07-21 | AA | accounts | accounts with accounts type full |
| 2023-09-25 | AD01 | address | change registered office address company with date old address new address |
| 2023-08-18 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2023-08-15 | AA | accounts | accounts with accounts type full |
| 2022-08-15 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2022-08-08 | MA | incorporation | memorandum articles |
| 2022-08-08 | RESOLUTIONS | resolution | resolution |
| 2022-08-05 | AA | accounts | accounts with accounts type full |
| 2021-08-23 | CS01 | confirmation-statement | confirmation statement with no updates |
| 2021-08-20 | PSC07 | persons-with-significant-control | cessation of a person with significant control |
| 2021-08-20 | PSC02 | persons-with-significant-control | notification of a person with significant control |
| 2021-08-19 | CH01 | officers | change person director company with change date |
Credit score
Altman Z″ — composite of working capital, retained earnings, EBIT, and leverage
Activity Score
Filings velocity, capital events, officer churn, accounts trajectory